Merck Total Stockholder Equity vs Common Stock Shares Outstanding Analysis

MRK Stock

USD 131.20 0.48 0.37%

Merck financial indicator trend analysis is infinitely more than just investigating Merck Company recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Merck Company is a good investment. Please check the relationship between Merck Total Stockholder Equity and its Common Stock Shares Outstanding accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Total Stockholder Equity vs Common Stock Shares Outstanding

Total Stockholder Equity vs Common Stock Shares Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Merck Company Total Stockholder Equity account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have strong relationship.

The correlation between Merck's Total Stockholder Equity and Common Stock Shares Outstanding is 0.67. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of Merck Company, assuming nothing else is changed. The correlation between historical values of Merck's Total Stockholder Equity and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Merck Company are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Total Stockholder Equity i.e., Merck's Total Stockholder Equity and Common Stock Shares Outstanding go up and down completely randomly.

Correlation Coefficient

0.67

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Most indicators from Merck's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Merck Company current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

At this time, Merck's Selling General Administrative is quite stable compared to the past year. Sales General And Administrative To Revenue is expected to rise to 0.18 this year, although the value of Tax Provision will most likely fall to about 2.2 B.

	2021	2022	2023	2024 (projected)
Gross Profit	35.1B	41.9B	43.9B	46.1B
Total Revenue	48.7B	59.3B	59.9B	32.5B

Gross Profit Total Revenue

Merck fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Property Plant And Equipment Gross	Common Stock Total Equity	Short Term Investments
Total Assets		0.57	0.72	0.79	0.87	0.53	0.28	0.88	0.73	1.0	0.22	0.74	0.61	0.3	0.74	0.93	0.59	0.15	0.7	0.98	0.3	0.8	0.49	0.27	0.95	0.16
Short Long Term Debt Total	0.57		0.92	0.75	0.25	0.89	0.91	0.75	0.2	0.59	0.69	0.11	0.9	-0.27	0.95	0.58	0.95	-0.55	0.97	0.5	0.27	0.24	0.76	0.75	0.64	-0.24
Other Current Liab	0.72	0.92		0.85	0.42	0.81	0.78	0.9	0.35	0.74	0.57	0.31	0.84	-0.19	0.94	0.71	0.89	-0.46	0.96	0.67	0.3	0.4	0.82	0.64	0.77	-0.1
Total Current Liabilities	0.79	0.75	0.85		0.4	0.61	0.6	0.93	0.42	0.81	0.64	0.28	0.63	-0.25	0.77	0.86	0.68	-0.43	0.82	0.73	0.52	0.37	0.86	0.4	0.87	-0.17
Total Stockholder Equity	0.87	0.25	0.42	0.4		0.33	-0.07	0.59	0.79	0.84	-0.17	0.9	0.43	0.67	0.47	0.72	0.36	0.57	0.4	0.9	0.08	0.93	0.05	0.1	0.72	0.37
Property Plant And Equipment Net	0.53	0.89	0.81	0.61	0.33		0.74	0.65	0.33	0.53	0.7	0.13	0.98	-0.14	0.84	0.57	0.93	-0.36	0.87	0.5	0.15	0.39	0.62	0.89	0.53	-0.4
Net Debt	0.28	0.91	0.78	0.6	-0.07	0.74		0.57	-0.21	0.33	0.65	-0.22	0.75	-0.51	0.8	0.28	0.84	-0.73	0.83	0.18	0.11	-0.09	0.73	0.71	0.41	-0.2
Retained Earnings	0.88	0.75	0.9	0.93	0.59	0.65	0.57		0.48	0.89	0.49	0.45	0.69	-0.14	0.82	0.84	0.76	-0.31	0.83	0.84	0.26	0.5	0.8	0.48	0.9	0.01
Cash	0.73	0.2	0.35	0.42	0.79	0.33	-0.21	0.48		0.69	0.1	0.8	0.35	0.54	0.38	0.75	0.24	0.44	0.35	0.8	0.41	0.81	0.11	0.07	0.6	-0.08
Non Current Assets Total	1.0	0.59	0.74	0.81	0.84	0.53	0.33	0.89	0.69		0.25	0.69	0.62	0.26	0.76	0.92	0.6	0.11	0.72	0.96	0.3	0.79	0.53	0.28	0.95	0.13
Non Currrent Assets Other	0.22	0.69	0.57	0.64	-0.17	0.7	0.65	0.49	0.1	0.25		-0.34	0.62	-0.63	0.53	0.4	0.63	-0.72	0.61	0.16	0.36	-0.09	0.8	0.71	0.3	-0.76
Cash And Short Term Investments	0.74	0.11	0.31	0.28	0.9	0.13	-0.22	0.45	0.8	0.69	-0.34		0.21	0.74	0.34	0.63	0.17	0.61	0.28	0.83	0.2	0.79	-0.1	-0.16	0.62	0.52
Net Receivables	0.61	0.9	0.84	0.63	0.43	0.98	0.75	0.69	0.35	0.62	0.62	0.21		-0.04	0.9	0.62	0.93	-0.29	0.91	0.57	0.13	0.47	0.6	0.83	0.62	-0.28
Common Stock Shares Outstanding	0.3	-0.27	-0.19	-0.25	0.67	-0.14	-0.51	-0.14	0.54	0.26	-0.63	0.74	-0.04		-0.05	0.23	-0.2	0.92	-0.12	0.38	0.08	0.67	-0.61	-0.38	0.19	0.47
Non Current Liabilities Total	0.74	0.95	0.94	0.77	0.47	0.84	0.8	0.82	0.38	0.76	0.53	0.34	0.9	-0.05		0.71	0.9	-0.34	0.99	0.68	0.27	0.47	0.7	0.63	0.79	-0.1
Inventory	0.93	0.58	0.71	0.86	0.72	0.57	0.28	0.84	0.75	0.92	0.4	0.63	0.62	0.23	0.71		0.55	0.03	0.72	0.92	0.53	0.72	0.57	0.25	0.94	-0.05
Other Current Assets	0.59	0.95	0.89	0.68	0.36	0.93	0.84	0.76	0.24	0.6	0.63	0.17	0.93	-0.2	0.9	0.55		-0.43	0.92	0.54	0.13	0.34	0.69	0.86	0.59	-0.19
Other Stockholder Equity	0.15	-0.55	-0.46	-0.43	0.57	-0.36	-0.73	-0.31	0.44	0.11	-0.72	0.61	-0.29	0.92	-0.34	0.03	-0.43		-0.42	0.23	-0.12	0.57	-0.74	-0.48	-0.03	0.46
Total Liab	0.7	0.97	0.96	0.82	0.4	0.87	0.83	0.83	0.35	0.72	0.61	0.28	0.91	-0.12	0.99	0.72	0.92	-0.42		0.64	0.35	0.4	0.75	0.66	0.77	-0.17
Total Current Assets	0.98	0.5	0.67	0.73	0.9	0.5	0.18	0.84	0.8	0.96	0.16	0.83	0.57	0.38	0.68	0.92	0.54	0.23	0.64		0.31	0.82	0.4	0.22	0.91	0.21
Short Term Debt	0.3	0.27	0.3	0.52	0.08	0.15	0.11	0.26	0.41	0.3	0.36	0.2	0.13	0.08	0.27	0.53	0.13	-0.12	0.35	0.31		0.12	0.3	-0.16	0.41	-0.27
Intangible Assets	0.8	0.24	0.4	0.37	0.93	0.39	-0.09	0.5	0.81	0.79	-0.09	0.79	0.47	0.67	0.47	0.72	0.34	0.57	0.4	0.82	0.12		0.07	0.16	0.65	0.15
Accounts Payable	0.49	0.76	0.82	0.86	0.05	0.62	0.73	0.8	0.11	0.53	0.8	-0.1	0.6	-0.61	0.7	0.57	0.69	-0.74	0.75	0.4	0.3	0.07		0.57	0.58	-0.37
Property Plant And Equipment Gross	0.27	0.75	0.64	0.4	0.1	0.89	0.71	0.48	0.07	0.28	0.71	-0.16	0.83	-0.38	0.63	0.25	0.86	-0.48	0.66	0.22	-0.16	0.16	0.57		0.22	-0.48
Common Stock Total Equity	0.95	0.64	0.77	0.87	0.72	0.53	0.41	0.9	0.6	0.95	0.3	0.62	0.62	0.19	0.79	0.94	0.59	-0.03	0.77	0.91	0.41	0.65	0.58	0.22		0.14
Short Term Investments	0.16	-0.24	-0.1	-0.17	0.37	-0.4	-0.2	0.01	-0.08	0.13	-0.76	0.52	-0.28	0.47	-0.1	-0.05	-0.19	0.46	-0.17	0.21	-0.27	0.15	-0.37	-0.48	0.14

Click cells to compare fundamentals

Merck Account Relationship Matchups

Merck fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	84.4B	91.6B	105.7B	109.2B	106.7B	60.3B
Short Long Term Debt Total	26.3B	31.8B	33.1B	30.7B	36.3B	38.1B
Other Current Liab	14.9B	16.3B	16.9B	18.0B	15.5B	16.3B
Total Current Liabilities	22.2B	27.3B	23.9B	24.2B	25.7B	13.3B
Total Stockholder Equity	25.9B	25.3B	38.2B	46.0B	37.6B	25.5B
Property Plant And Equipment Net	15.1B	18.0B	19.3B	21.4B	24.5B	25.7B
Net Debt	16.7B	23.7B	25.0B	18.0B	29.4B	30.8B
Retained Earnings	46.6B	47.4B	53.7B	61.1B	53.9B	32.6B
Cash	9.7B	8.1B	8.1B	12.7B	6.9B	5.6B
Non Current Assets Total	56.9B	63.8B	75.4B	73.4B	74.5B	41.1B
Non Currrent Assets Other	5.3B	9.2B	8.1B	7.7B	9.2B	6.1B
Cash And Short Term Investments	10.5B	8.1B	8.1B	13.2B	7.2B	7.3B
Net Receivables	6.8B	7.9B	9.2B	9.5B	11.1B	11.6B
Common Stock Shares Outstanding	2.6B	2.5B	2.5B	2.5B	2.5B	2.7B
Liabilities And Stockholders Equity	84.4B	91.6B	105.7B	109.2B	106.7B	60.3B
Non Current Liabilities Total	36.2B	38.9B	43.6B	38.9B	43.3B	45.5B
Inventory	6.0B	6.3B	6.0B	5.9B	6.4B	3.7B
Other Current Assets	4.3B	5.5B	7.0B	7.2B	7.6B	8.0B
Other Stockholder Equity	(16.3B)	(17.2B)	(12.9B)	(12.1B)	(12.9B)	(12.3B)
Total Liab	58.4B	66.2B	67.4B	63.1B	69.0B	72.5B
Total Current Assets	27.5B	27.8B	30.3B	35.7B	32.2B	19.2B
Short Term Debt	3.6B	6.4B	2.4B	1.9B	1.7B	2.3B
Intangible Assets	14.2B	14.6B	22.9B	20.3B	18.0B	14.3B
Accounts Payable	3.7B	4.6B	4.6B	4.3B	3.9B	2.8B
Property Plant And Equipment Gross	15.1B	18.0B	37.5B	39.4B	41.3B	43.4B
Accumulated Other Comprehensive Income	(6.2B)	(6.6B)	(4.4B)	(4.8B)	(5.2B)	(4.9B)
Short Term Investments	774M	1M	0.0	498M	252M	239.4M
Other Liab	12.7B	12.1B	11.7B	9.1B	10.5B	10.2B
Other Assets	5.3B	7.8B	9.4B	7.4B	8.5B	5.5B
Long Term Debt	22.7B	25.4B	30.7B	28.7B	33.7B	17.2B
Good Will	19.4B	20.2B	21.3B	21.2B	21.2B	12.3B
Treasury Stock	(56.0B)	(56.8B)	(57.1B)	(56.5B)	(57.5B)	(54.6B)
Property Plant Equipment	15.1B	18.0B	19.3B	21.4B	24.6B	16.2B
Net Tangible Assets	(7.7B)	(9.5B)	3.5B	4.5B	4.1B	4.5B
Noncontrolling Interest In Consolidated Entity	94M	87M	73M	67M	54M	51.3M

Merck Investors Sentiment

The influence of Merck's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Merck. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Merck's public news can be used to forecast risks associated with an investment in Merck. The trend in average sentiment can be used to explain how an investor holding Merck can time the market purely based on public headlines and social activities around Merck Company. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Merck's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Merck's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Merck's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Merck.

Merck Implied Volatility

21.14

Merck's implied volatility exposes the market's sentiment of Merck Company stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Merck's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Merck stock will not fluctuate a lot when Merck's options are near their expiration.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Merck in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Merck's short interest history, or implied volatility extrapolated from Merck options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:

How To Invest In Merck

Details

Is Merck Stock a good investment?

Details

What is Merck's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Merck Stock analysis

When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.

	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Stocks Directory Find actively traded stocks across global markets
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals

Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.453

Dividend Share

2.92

Earnings Share

0.14

Revenue Per Share

23.695

Quarterly Revenue Growth

0.058

The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Merck Total Stockholder Equity vs Common Stock Shares Outstanding Analysis

Total Stockholder Equity vs Common Stock Shares Outstanding

Total Stockholder Equity vs Common Stock Shares Outstanding Correlation Analysis

Correlation Coefficient

Total Stockholder Equity

Common Stock Shares Outstanding

Merck fundamental ratios Correlations

Merck Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Merck fundamental ratios Accounts

Merck Investors Sentiment

Merck Implied Volatility

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Merck Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Total Liab	+ 0.99	Non Current Liabilities Total
Total Current Assets	+ 0.98	Total Assets
Net Receivables	+ 0.98	Property Plant And Equipment Net
Total Liab	+ 0.97	Short Long Term Debt Total
Total Liab	+ 0.96	Other Current Liab

Short Term Investments	- 0.76	Non Currrent Assets Other
Accounts Payable	- 0.74	Other Stockholder Equity
Other Stockholder Equity	- 0.73	Net Debt
Other Stockholder Equity	- 0.72	Non Currrent Assets Other
Common Stock Shares Outstanding	- 0.63	Non Currrent Assets Other
Accounts Payable	- 0.61	Common Stock Shares Outstanding